Literature DB >> 16838152

Peptide-cleaving catalyst selective for melanin-concentrating hormone: Oxidative decarboxylation of N-terminal aspartate catalyzed by Co(III)cyclen.

Min Gyum Kim1, Myoung-soon Kim, Seong Du Lee, Junghun Suh.   

Abstract

To provide a firm basis for the new paradigm of drug discovery based on catalysts for oxidative cleavage of N-terminal aspartate (Asp) residues of oligopeptides, oligopeptide-cleaving catalysts were searched by using melanin-concentrating hormone (MCH) as the substrate. MCH is a target for designing drugs to reduce obesity. Catalyst candidates containing the Co(III) complex of cyclen as the catalytic center were prepared by multicomponent condensation reactions. From three kinds of chemical libraries containing about 19,000 catalyst candidates, one compound was identified as the MCH-cleaving catalyst. On incubation with the catalyst, the N-terminal Asp residue of MCH was converted to the pyruvate residue by oxidative decarboxylation. Detailed kinetics analysis revealed the catalytic nature of the action of the catalyst. In addition, the kinetics data indicated that MCH can be cleaved with half-lives of 3 h or less with submicromolar catalyst concentrations if the structure of the catalyst is further improved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838152     DOI: 10.1007/s00775-006-0139-0

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  14 in total

1.  Multicomponent Reactions with Isocyanides.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-09-15       Impact factor: 15.336

Review 2.  Synthetic artificial peptidases and nucleases using macromolecular catalytic systems.

Authors:  Junghun Suh
Journal:  Acc Chem Res       Date:  2003-07       Impact factor: 22.384

3.  Peptide-cleaving catalyst selective for peptide deformylase.

Authors:  Pil Seok Chae; Myoung-Soon Kim; Chul-Seung Jeung; Seong Du Lee; Hwangseo Park; Sangyoub Lee; Junghun Suh
Journal:  J Am Chem Soc       Date:  2005-03-02       Impact factor: 15.419

4.  17 alpha-O-(aminoalkyl)oxime derivatives of 3 beta,14 beta-dihydroxy-5 beta-androstane and 3 beta-hydroxy-14-oxoseco-D-5 beta-androstane as inhibitors of Na(+),K(+)-ATPase at the digitalis receptor.

Authors:  M Gobbini; P Barassi; A Cerri; S De Munari; G Fedrizzi; M Santagostino; A Schiavone; M Torri; P Melloni
Journal:  J Med Chem       Date:  2001-11-08       Impact factor: 7.446

5.  Kinetic origin of the chelate effect. Base hydrolysis, H-exchange reactivity, and structures of syn,anti-[Co(cyclen)(NH3)2]3+ and syn,anti-[Co(cyclen)(diamine)]3+ ions (diamine = H2N(CH2)2NH2, H2N(CH2)3NH2).

Authors:  A J Clarkson; D A Buckingham; A J Rogers; A G Blackman; C R Clark
Journal:  Inorg Chem       Date:  2000-10-16       Impact factor: 5.165

6.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism.

Authors:  Donald J Marsh; Drew T Weingarth; Dawn E Novi; Howard Y Chen; Myrna E Trumbauer; Airu S Chen; Xiao-Ming Guan; Michael M Jiang; Yue Feng; Ramon E Camacho; Zhu Shen; Easter G Frazier; Hong Yu; Joseph M Metzger; Stephanie J Kuca; Lauren P Shearman; Shobhna Gopal-Truter; Douglas J MacNeil; Alison M Strack; D Euan MacIntyre; Lex H T Van der Ploeg; Su Qian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

Review 7.  Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.

Authors:  R M Touyz; E L Schiffrin
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

8.  Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype.

Authors:  Gabriella Segal-Lieberman; Richard L Bradley; Efi Kokkotou; Michael Carlson; Daniel J Trombly; Xiaomei Wang; Sarah Bates; Martin G Myers; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

9.  Melanin-concentrating hormone receptor mutations and human obesity: functional analysis.

Authors:  William T Gibson; Pavlos Pissios; Daniel J Trombly; Jian'an Luan; Julia Keogh; Nicholas J Wareham; Eleftheria Maratos-Flier; Stephen O'Rahilly; I Sadaf Farooqi
Journal:  Obes Res       Date:  2004-05

10.  Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity.

Authors:  Christopher G Bell; David Meyre; Chantal Samson; Cliona Boyle; Cécile Lecoeur; Maïte Tauber; Béatrice Jouret; Delphine Jaquet; Claire Levy-Marchal; Marie Aline Charles; Jacques Weill; Fernando Gibson; Charles A Mein; Philippe Froguel; Andrew J Walley
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

View more
  3 in total

1.  Cleavage agents for soluble oligomers of human islet amyloid polypeptide.

Authors:  Junghun Suh; Woo Suk Chei; Tae Yeon Lee; Min Gyum Kim; Sang Ho Yoo; Keunhong Jeong; Jae Young Ahn
Journal:  J Biol Inorg Chem       Date:  2008-03-05       Impact factor: 3.358

2.  Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelates.

Authors:  Jeff C Joyner; Lalintip Hocharoen; J A Cowan
Journal:  J Am Chem Soc       Date:  2012-02-10       Impact factor: 15.419

Review 3.  Target-directed catalytic metallodrugs.

Authors:  J C Joyner; J A Cowan
Journal:  Braz J Med Biol Res       Date:  2013-07-02       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.